MR
Marco Ruella's research focuses on cellular immunotherapies, including chimeric antigen receptor T cells for hematologic malignancies. His work investigates mechanisms of treatment resistance and strategies to improve engineered T-cell therapies.
- Field
- Medicine · Hematology
- Clarivate categories
- Cross-Field
- Affiliation
- University of Pennsylvania, United States